Wael Soliman1, Henrik Lund-Andersen, Michael Larsen. Show Affiliations » 1. Department of Ophthalmology, Herlev Hospital, University of Copenhagen, Herlev, Denmark. waeso101@herlevhosp.kbhamt.dk
Abstract
Entities: Chemical Disease
Mesh: See more » AdultAngiogenesis Inhibitors/therapeutic useAntibodies, Monoclonal/therapeutic useAntibodies, Monoclonal, HumanizedBevacizumabBody Fluids/metabolismChoroidal Neovascularization/diagnosisChoroidal Neovascularization/drug therapyExudates and Transudates/metabolismFemaleFluorescein AngiographyHumansInjectionsRetinal Hemorrhage/diagnosisRetinal Hemorrhage/drug therapyRetinal Hemorrhage/metabolismRetinal Neovascularization/diagnosisRetinal Neovascularization/drug therapyTomography, Optical CoherenceVascular Endothelial Growth Factor A/antagonists & inhibitorsVisual AcuityVitreous Body
Substances: See more » Angiogenesis InhibitorsAntibodies, MonoclonalAntibodies, Monoclonal, HumanizedVEGFA protein, humanVascular Endothelial Growth Factor ABevacizumab
Year: 2006 PMID: 16965507 DOI: 10.1111/j.1600-0420.2006.00736.x
Source DB: PubMed Journal: Acta Ophthalmol Scand ISSN: 1395-3907